Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$134M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| KARABELAS ARGERIS N | Oct 1, 2024 | Sell | 10,000 | $10.1052 | $100,000 |
| KARABELAS ARGERIS N | Sep 3, 2024 | Sell | 9,300 | $11.5 | $110,000 |
| KARABELAS ARGERIS N | Sep 3, 2024 | Sell | 700 | $12.34 | $8,600 |
| KARABELAS ARGERIS N | Aug 1, 2024 | Sell | 9,600 | $13.45 | $130,000 |
| KARABELAS ARGERIS N | Aug 1, 2024 | Sell | 400 | $14.585 | $5,800 |
| KARABELAS ARGERIS N | Aug 1, 2024 | Sell | 100 | $15 | $1,500 |
| Simpson Curran | Aug 1, 2024 | Sell | 100 | $15 | $1,500 |
| KARABELAS ARGERIS N | Jul 29, 2024 | Sell | 11,000 | $15.045 | $170,000 |
| Simpson Curran | Jul 29, 2024 | Sell | 9,648 | $15.04 | $150,000 |
| Mills Kenneth T. | Jul 25, 2024 | Sell | 15,369 | $13.9567 | $210,000 |
| Mills Kenneth T. | Jul 24, 2024 | Sell | 12,221 | $13.7823 | $170,000 |
| Mills Kenneth T. | Jul 17, 2024 | Sell | 2,210 | $13.7737 | $30,000 |
| Mills Kenneth T. | Jul 16, 2024 | Sell | 200 | $13.76 | $2,800 |
| KARABELAS ARGERIS N | Jul 1, 2024 | Sell | 10,000 | $11.2691 | $110,000 |
| Mills Kenneth T. | May 14, 2024 | Sell | 15,000 | $15.8148 | $240,000 |
| Mills Kenneth T. | Apr 15, 2024 | Sell | 15,000 | $18.1914 | $270,000 |
| Mills Kenneth T. | Mar 14, 2024 | Sell | 15,000 | $21.8628 | $330,000 |
| PAKOLA STEVE | Mar 5, 2024 | Sell | 12,878 | $28.36 | $370,000 |
| Mills Kenneth T. | Feb 14, 2024 | Sell | 10,348 | $16.8847 | $170,000 |
| Mills Kenneth T. | Feb 14, 2024 | Sell | 4,652 | $16.4716 | $77,000 |
| Mills Kenneth T. | Jan 16, 2024 | Sell | 45,000 | $15.1776 | $680,000 |
| PAKOLA STEVE | Jan 3, 2024 | Sell | 17,237 | $17.3922 | $300,000 |
| Mills Kenneth T. | Dec 19, 2023 | Sell | 45,000 | $19.685 | $890,000 |
| PAKOLA STEVE | Jan 3, 2023 | Sell | 3,138 | $22.1668 | $70,000 |
What's the latest insider transaction for Regenxbio?
The most recent insider transaction for Regenxbio was conducted by KARABELAS ARGERIS N, who sold 10,000 shares on October 1, 2024 at a price of $10.11 per share.
Which insider has sold the most RGNX stock over the last two years?
Mills Kenneth T. has sold the most RGNX stock in the last 2 years, with a total value of $3.1M.
What is the total value of insider transactions for Regenxbio (RGNX) in the last 2 years?
The total value of insider transactions for Regenxbio in the last 2 years is negative, amounting to -$4.6M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Regenxbio's market confidence?
Over the last 2 years, insider transactions for Regenxbio have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
